Hainan Huluwa Pharmaceutical Group Co Ltd (605199) — Cash Flow Reinvestment Rate
Hainan Huluwa Pharmaceutical Group Co Ltd (605199) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥9.15 Million (capex CN¥9.15 Million ) from operating cash flow of CN¥44.34 Million. See 605199 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hainan Huluwa Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Hainan Huluwa Pharmaceutical Group Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hainan Huluwa Pharmaceutical Group Co Lt.
Annual Cash Flow Reinvestment Rate for Hainan Huluwa Pharmaceutical Group Co Ltd (2016–2025)
Year-by-year capital reinvestment analysis for Hainan Huluwa Pharmaceutical Group Co Ltd. See 605199 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.61x | CN¥83.67 Million | CN¥136.85 Million | CN¥83.67 Million | ▼ -98.3% |
| 2023 | 35.87x | CN¥1.01 Billion | CN¥28.25 Million | CN¥489.20 Million | ▲ +1979.0% |
| 2022 | 1.73x | CN¥411.86 Million | CN¥238.71 Million | CN¥392.32 Million | ▲ +28.4% |
| 2021 | 1.34x | CN¥137.74 Million | CN¥102.48 Million | CN¥137.62 Million | ▼ -92.7% |
| 2020 | 18.53x | CN¥61.14 Million | CN¥3.30 Million | CN¥59.42 Million | ▲ +4256.9% |
| 2019 | 0.43x | CN¥61.45 Million | CN¥144.51 Million | CN¥58.40 Million | ▼ -82.1% |
| 2018 | 2.37x | CN¥75.34 Million | CN¥31.80 Million | CN¥72.82 Million | ▲ +34.7% |
| 2017 | 1.76x | CN¥158.23 Million | CN¥89.96 Million | CN¥157.58 Million | ▲ +9.5% |
| 2016 | 1.61x | CN¥104.40 Million | CN¥64.96 Million | CN¥40.99 Million | — |